Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep 4:6:47-55.
doi: 10.4137/IJTR.S12536.

Kynurenic Acid in the digestive system-new facts, new challenges

Michal P Turski  1 , Monika Turska, Piotr Paluszkiewicz, Jolanta Parada-Turska, Gregory F Oxenkrug
Affiliations
Review

Kynurenic Acid in the digestive system-new facts, new challenges

Michal P Turski et al. Int J Tryptophan Res. .

Abstract

This review provides information on the most recent findings concerning presence, origin, and role of kynurenic acid (KYNA), a tryptophan metabolite, in the digestive system. KYNA is an antagonist of both the ionotropic glutamate receptors and the alpha7 nicotinic acetylcholine receptor, as well as an agonist of G-protein coupled GPR35 receptor. Since the GPR35 receptor is mainly present in the gastrointestinal tract, researchers have concentrated on the digestive system in recent years. They have found that KYNA content increases gradually and significantly along the gastrointestinal tract. Interestingly, the concentration of KYNA in the lumen is much higher than in the wall of intestine. It has been documented that KYNA may have a positive influence on the number of pathologies in the gastrointestinal tract, in particular ulcers, colon obstruction, or colitis. Future studies might determine whether it is advisable to supplement KYNA to a human organism.

Keywords: digestive system; food; herb; kynurenic acid; pathophysiology.

PubMed Disclaimer

References

    1. Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci. 2012;13:465–77. - PMC - PubMed
    1. Adams S, Braidy N, Bessede A, et al. The kynurenine pathway in brain tumor pathogenesis. Cancer Res. 2012;72:5649–57. - PubMed
    1. Liebig J. Über Kynurensäure. Justus Liebigs Ann Chem. 1853;86:125–6.
    1. Alt A, Weiss B, Ogden AM, et al. Pharmacological characterization of glutamatergic agonists and antagonists at recombinant human homomeric and heteromeric kainate receptors in vitro. Neuropharmacology. 2004;46:793–806. - PubMed
    1. Ganong AH, Cotman CW. Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus. J Pharmacol Exp Ther. 1986;236:293–9. - PubMed